All News

Chicago-Initial analyses from a retrospective study involving almost 600 men undergoing prostate needle biopsy show no association between inflammation on initial or subsequent biopsy and prostate cancer. However, the investigators from Harvard Medical School are withholding any conclusions while they continue their research.

Chicago-Although open radical prostatectomy remains the gold standard of treatment for clinically localized prostate cancer, laparoscopic prostatectomy and, more recently, robot-assisted laparoscopic prostatectomy are rapidly increasing in popularity as alternatives to traditional open prostatectomy techniques.

Chicago-In 2000, the American Board of Medical Specialties assembly voted to commit member boards to Maintenance of Certification for their diplomates holding time-limited certificates. The American Board of Urology will introduce its MOC program in 2007, but during its development, the ABU has received a number of complaints and questions about MOC from urologists.

Maintenance of Certification (MOC) has become a controversial topic among practicing urologists since the concept was first introduced by the American Board of Medical Specialties (ABMS) 8 years ago. As work on a final MOC plan for urologists continues, the American Board of Urology (ABU) says its plan will be flexible in format, relevant to clinical practice, and not overly burdensome. In this exclusive interview, current ABU President Linda D. Shortliffe, MD, outlines details of the program and how it will relate to actual practice.

Chicago-Volumetric three-dimensional magnetic resonance urography (MRU) is a new imaging modality that is already proving to be a valuable tool for enhancing the diagnosis of various urologic conditions in pediatric patients. In addition, with a potential for use in functional and dynamic imaging, it may ultimately take on a greater role and enable streamlining of the algorithm for diagnostic evaluation, said urologists from Children's Hospital of Los Angeles (CHLA) and the University of Southern California.

A branch of the National Institutes of Health announced an early end to two clinical trials of adult male circumcision because an interim review of trial data revealed that medically performed circumcision significantly reduces a man's risk of acquiring HIV through heterosexual intercourse.

Patients with overactive bladder who are treated with solifenacin succinate (Vesicare) experience statistically significant reductions in episodes of urgency, suggests a study presented at the International Continence Society annual meeting in Christchurch, New Zealand.

Men between 65 and 80 years of age who receive treatment for early-stage, localized prostate cancer appear to live significantly longer than men who do not receive treatment, according to the authors of a retrospective study from the University of Pennsylvania School of Medicine, Philadelphia.

Congress has passed legislation to prevent a scheduled 5% cut in 2007 Medicare physician payments and instead will freeze payment rates for 1 year.

A substantial, yet unrecognized age-dependent population-level decrease in testosterone in American men has been observed, potentially due to birth cohort differences or to health or environmental effects not captured in observed data, suggest researchers from the New England Research Institutes, Watertown, MA.

Early research on the use of gene transfer to treat erectile dysfunction shows promising results and suggests the potential for using the technology to treat overactive bladder and other conditions, according to researchers from North Carolina and New York.

Cleveland-Intraprostatic injection of mepivacaine epinephrine through a specialized catheter reduces the need for analgesia, as well as treatment time and energy consumption in patients undergoing high-energy transurethral microwave thermotherapy (TUMT) for BPH, researchers reported here.

Chicago-Although chemotherapy reigns supreme as the most effective systemic therapy to treat advanced prostate cancer, it is being contested with the rapid emergence and development of novel agents that are showing great promise in targeting pathways of cancer without causing damage to normal cells. However, it doesn't appear that chemotherapy will be relegated to the history books any time soon. Even if targeted therapies prove to be all they promise they may be, chemotherapy may still be essential.

Chicago-With the evolving definition of advanced prostate cancer that now includes a number of clinical states not previously defined, treatment has also evolved into a multimodal approach. This mandates close cooperation among urologists and medical and radiation oncologists to ensure optimal patient care, according to leading oncologists.

Chicago-One of the most difficult issues in the management of prostate cancer is identifying which men with indolent disease are at increased risk of progressing to more advanced disease. Reliance on traditional clinical prognostic factors, including PSA, has provided some guidance on treatment, but all too often, men with indolent disease are over-treated based on an incomplete knowledge of disease risk.